The Potential Downsides of New Blockbuster Obesity Drugs
July 31, 2023
(Axios) – Even as encouraging data fuels hype around a new class of obesity drugs, regulators and experts are racing to better understand possible health risks that are still emerging in a market projected to be worth tens of billions of dollars. Why it matters: Weight-loss drugs like Ozempic have quickly become a cultural phenomenon and a source of hope for people with obesity and related health conditions. But recent reports of potential side effects, including suicidal thoughts, have raised concerns. (Read More)